loader image

Company/MAH Recall Announcement

This section provides information on the press release or notice to the public of a certain marketing authorization holder when a recall of their product is pursued. FDA Philippines posts the advisory of the company as a public service but does not endorse either the product or the company. For additional information on recalls, see https://www.fda.gov.ph/category/drugs-advisories/.

DATEPRODUCT DESCRIPTIONBRAND NAMEMAHREASON FOR RECALLANNOUNCEMENT
12 March 2021Amoxicillin (as trihydrate) 125 mg/5 mL Powder for SuspensionHimoxUNILAB, Inc.Misprinting of LabelsView PDF
01 March 2021Cloxacillin (as sodium) 500mg capsule (Philclox)PhilcloxPhilRx Pharma Inc.Out-of-SpecificationView PDF
24 February 2021Sertraline (as Hydrochloride) 50 mg Film-Coated TabletSerenata
Torrent Pharma Philippines, Inc.Out-of-SpecificationView PDF
08 January 2021Ceftolozane + Tazobactam 1 g/500 mg Powder for Injection (IV)ZerbaxaMerck Sharp & Dohme (I.A.) LLCOut-of-SpecificationView PDF